Syncom Formulations (India) Limited - ROE

The ROE as of October 2026 (TTM) for Syncom Formulations (India) Limited (SYNCOMF.NS) is 21.56%

According to Syncom Formulations (India) Limited’s latest financial reports and current stock price. The company's current ROE is 21.56%. This represents a change of 302.29% compared to the average of 5.36% of the last 4 quarters.

Syncom Formulations (India) Limited (SYNCOMF.NS) Historical ROE (quarterly & annually)

How has SYNCOMF.NS ROE performed in the past?

The mean historical ROE of Syncom Formulations (India) Limited over the last ten years is 10.82%. The current 21.56% ROE has changed 99.31% with respect to the historical average. Over the past ten years (40 quarters), SYNCOMF.NS's ROE was at its highest in in the December 2020 quarter at 6.34%. The ROE was at its lowest in in the June 2016 quarter at 0%.

Syncom Formulations (India) Limited (SYNCOMF.NS) ROE by Quarter and Year

Discovering the peaks and valleys of Syncom Formulations (India) Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Syncom Formulations (India) Limited (SYNCOMF.NS) Average ROE

How has SYNCOMF.NS ROE performed in the past?

The current ROE of Syncom Formulations (India) Limited (SYNCOMF.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Syncom Formulations (India) Limited (SYNCOMF.NS) ROE vs. Peers

How is SYNCOMF.NS’s ROE compared to its peers?

Syncom Formulations (India) Limited’s ROE is less than Jagsonpal Pharmaceuticals Limited (17.19%), less than Bajaj Healthcare Ltd (3.46%), less than Jagsonpal Pharmaceuticals Limited (17.19%), less than Bajaj Healthcare Ltd (3.46%), less than Bliss GVS Pharma Limited (11.53%), less than Bliss GVS Pharma Limited (11.53%), less than Sigma Advanced Systems Limited (88.80%), less than Hester Biosciences Limited (38.44%), less than Hester Biosciences Limited (38.44%), less than TTK Healthcare Limited (6.72%),

Build a custom stock screener for Syncom Formulations (India) Limited (SYNCOMF.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Syncom Formulations (India) Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Syncom Formulations (India) Limited (SYNCOMF.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Syncom Formulations (India) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.